SCHEMBL18852810

SCHEMBL18852810

Cc1nc(C)c2c(n1)oc1cc3ccccc3cc12

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ELANE P08246 1/20 0.37
▸ EGFR P00533 3/20 0.36
▸ KDR P35968 3/20 0.36
▸ NQO1 P15559 1/20 0.34
▸ PRKDC P78527 3/20 0.34
▸ DYRK1A Q13627 1/20 0.34
▸ SMN1; SMN2 Q16637 7/20 0.33
▸ KMT2A Q03164 5/20 0.33
▸ MEN1 O00255 4/20 0.33
▸ LMNA P02545 2/20 0.33
▸ NPC1 O15118 2/20 0.33
▸ RAB9A P51151 2/20 0.33
▸ ALDH1A1 P00352 3/20 0.33
▸ HSD17B10 Q99714 2/20 0.33
▸ GAA P10253 1/20 0.33
▸ HTT P42858 1/20 0.33
▸ MAPT P10636 1/20 0.33
▸ NPSR1 Q6W5P4 1/20 0.32
▸ POLB P06746 1/20 0.32
▸ HPGD P15428 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25847178 0.81 SMN1; SMN2 (0.44) SMN1; SMN2KMT2AMEN1LMNANPC1
SCHEMBL27363853 0.79 MAOB (0.38) ELANEEGFRKDRSMN1; SMN2KMT2A
SCHEMBL18852799 0.77 HNF4A (0.47) EGFRKDRPRKDCSMN1; SMN2KMT2A
SCHEMBL18852816 0.74 KMT2A (0.47) SMN1; SMN2KMT2AMEN1LMNAALDH1A1
SCHEMBL18852791 0.73 KMT2A (0.45) EGFRKDRPRKDCKMT2AMEN1
SCHEMBL18595774 0.70 MAOA (0.41) ELANENQO1PRKDCDYRK1AKMT2A
SCHEMBL9779271 0.69 ALDH1A1 (0.42) ELANEDYRK1ASMN1; SMN2NPC1RAB9A
SCHEMBL18852818 0.69 GPR3 (0.35) EGFRKDRSMN1; SMN2KMT2AMEN1
SCHEMBL23944281 0.69 PRKDC (0.35) ELANEPRKDCDYRK1ASMN1; SMN2KMT2A
SCHEMBL19169964 0.68 HPGD (0.40) EGFRKDRPRKDCSMN1; SMN2KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170141331-A1 ORGANIC COMPOUND, ORGANIC OPTOELECTRONIC ELEMENT, AND DISPLAY DEVICE SAMSUNG SDI CO.,LTD. (KR) 2017-05-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170141331-A1 ORGANIC COMPOUND, ORGANIC OPTOELECTRONIC ELEMENT, AND DISPLAY DEVICE OCIAD1, OXER1, OCIAD2 ELANE 3382/4885EGFR 462/4885KDR 678/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback